Key challenges and future opportunities for LNP-based delivery

Lipid nanoparticles (LNPs) face a number of hurdles, including diverse challenges and considerations around safety, efficiency, and freedom to operate. David McCall, Senior Editor, BioInsights, talks to Julien Couture-Senécal, Co-Founder and Director of Azane Therapeutics, about the key remaining questions surrounding LNPs as they continue to gain traction in the nucleic acid delivery space and beyond.

Please enter your email to access content Read now